BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38423654)

  • 41. Ferroptosis: An emerging therapeutic opportunity for cancer.
    Wang L; Chen X; Yan C
    Genes Dis; 2022 Mar; 9(2):334-346. PubMed ID: 35224150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
    Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
    Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the Mitogen-Activated Protein Kinase Pathway on the Erastin-Induced Ferroptosis of Molt-4 Cells.
    Liu N; Liu G; Jiang H; Yu J; Jin Y; Wang H
    DNA Cell Biol; 2023 Jun; 42(6):348-356. PubMed ID: 37140570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid Peroxidation and GPX4 Inhibition Are Common Causes for Myofibroblast Differentiation and Ferroptosis.
    Gong Y; Wang N; Liu N; Dong H
    DNA Cell Biol; 2019 Jul; 38(7):725-733. PubMed ID: 31140862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRIM46 contributes to high glucose-induced ferroptosis and cell growth inhibition in human retinal capillary endothelial cells by facilitating GPX4 ubiquitination.
    Zhang J; Qiu Q; Wang H; Chen C; Luo D
    Exp Cell Res; 2021 Oct; 407(2):112800. PubMed ID: 34487731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
    Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
    J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
    Shibata Y; Yasui H; Higashikawa K; Miyamoto N; Kuge Y
    PLoS One; 2019; 14(12):e0225931. PubMed ID: 31800616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effect of hydnocarpin D on T-cell acute lymphoblastic leukemia via induction of autophagy-dependent ferroptosis.
    Lou S; Hong H; Maihesuti L; Gao H; Zhu Z; Xu L; Tian S; Kai G; Huang G; Zhao H
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1541-1553. PubMed ID: 33926261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GPX4 overexpression does not alter atherosclerotic plaque development in ApoE knock-out mice.
    Coornaert I; Breynaert A; Hermans N; De Meyer GRY; Martinet W
    Vasc Biol; 2024 Jan; 6(1):. PubMed ID: 38717303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer.
    Park SY; Jeong KJ; Poire A; Zhang D; Tsang YH; Blucher AS; Mills GB
    Cell Death Dis; 2023 Aug; 14(8):532. PubMed ID: 37596261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ferroptosis-inducing agents compromise in vitro human islet viability and function.
    Bruni A; Pepper AR; Pawlick RL; Gala-Lopez B; Gamble AF; Kin T; Seeberger K; Korbutt GS; Bornstein SR; Linkermann A; Shapiro AMJ
    Cell Death Dis; 2018 May; 9(6):595. PubMed ID: 29789532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
    Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
    Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mouse embryonic stem cell-derived motor neurons are susceptible to ferroptosis.
    Martinez AM; Kim A; Flores CA; Rahman DF; Yang WS
    FEBS Open Bio; 2023 Mar; 13(3):419-433. PubMed ID: 36595221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Theaflavin-3,3'-Digallate Inhibits Erastin-Induced Chondrocytes Ferroptosis via the Nrf2/GPX4 Signaling Pathway in Osteoarthritis.
    Xu C; Ni S; Xu N; Yin G; Yu Y; Zhou B; Zhao G; Wang L; Zhu R; Jiang S; Wang Y
    Oxid Med Cell Longev; 2022; 2022():3531995. PubMed ID: 36439689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells.
    Adedoyin O; Boddu R; Traylor A; Lever JM; Bolisetty S; George JF; Agarwal A
    Am J Physiol Renal Physiol; 2018 May; 314(5):F702-F714. PubMed ID: 28515173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hedgehog Stimulation Suppresses Clonogenicity and Activates NOTCH Signalling in T-lymphoblastic Leukaemia Jurkat Cells.
    Okuhashi Y; Itoh M; Tohda S
    Anticancer Res; 2017 Sep; 37(9):5005-5009. PubMed ID: 28870926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FOXP3 knockdown inhibits the proliferation and reduces NOTCH1 expression of T cell acute lymphoblastic leukemia cells.
    Yonekura S; Itoh M; Shiratori E; Ohtaka M; Tohda S
    BMC Res Notes; 2018 Aug; 11(1):582. PubMed ID: 30103821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual role of Nrf2/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells.
    Chen Z; Zhu Q; Qi X; Yang LR; Rong YX; Wei Q; Wu SQ; Lu QW; Li L; Jiang MD; Qi H
    Phytomedicine; 2024 Feb; 124():155288. PubMed ID: 38183698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.